Načítá se...
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab
A 68‐year‐old male patient with squamous cell carcinoma (cT4N2M0) of the left upper lobe received chemoradiotherapy followed by durvalumab, an immune checkpoint inhibitor. The tumour responded well to the therapy, but an infiltrative shadow appeared in the left upper lobe, which was outside the radi...
Uloženo v:
| Vydáno v: | Respirol Case Rep |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7211830/ https://ncbi.nlm.nih.gov/pubmed/32399215 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rcr2.580 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|